{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:37:38Z","timestamp":1770280658533,"version":"3.49.0"},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.5551\/jat.58909","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T22:06:31Z","timestamp":1614377191000},"page":"551-557","source":"Crossref","is-referenced-by-count":8,"title":["A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the &lt;i&gt;PCSK9&lt;\/i&gt; and &lt;i&gt;ABCG5&lt;\/i&gt; Genes and Type I CD36 Deficiency"],"prefix":"10.5551","volume":"29","author":[{"given":"Ryo","family":"Nishikawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Koseki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kujiraoka","sequence":"additional","affiliation":[{"name":"Research Department, R&D Center, BML"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hattori","sequence":"additional","affiliation":[{"name":"Research Department, R&D Center, BML"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Muranaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kokubu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjaerg-Hansen A, European Atherosclerosis Society Consensus P: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a","DOI":"10.1093\/eurheartj\/eht273"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrie A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ, Convened by the Familial Hypercholesterolemia F: Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol, 2018; 72: 662-680","DOI":"10.1016\/j.jacc.2018.05.044"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tada H, Kawashiri MA, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, Yamagishi M: Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol, 2018; 12: 1436-1444","DOI":"10.1016\/j.jacl.2018.08.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Park YM: CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med, 2014; 46: e99","DOI":"10.1038\/emm.2014.38"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Yanai H, Chiba H, Morimoto M, Abe K, Fujiwara H, Fuda H, Hui SP, Takahashi Y, Akita H, Jamieson GA, Kobayashi K, Matsuno K: Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet, 2000; 93: 299-304","DOI":"10.1002\/1096-8628(20000814)93:4<299::AID-AJMG9>3.0.CO;2-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Furuhashi M, Ura N, Nakata T, Shimamoto K: Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care, 2003; 26: 471-474","DOI":"10.2337\/diacare.26.2.471"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Masuda D, Hirano K, Oku H, Sandoval JC, Kawase R, Yuasa-Kawase M, Yamashita Y, Takada M, Tsubakio-Yamamoto K, Tochino Y, Koseki M, Matsuura F, Nishida M, Kawamoto T, Ishigami M, Hori M, Shimomura I, Yamashita S: Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res, 2009; 50: 999-1011","DOI":"10.1194\/jlr.P700032-JLR200"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yuasa-Kawase M, Masuda D, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Tsubakio-Yamamoto K, Ohama T, Matsuyama A, Nishida M, Ishigami M, Kawamoto T, Komuro I, Yamashita S: Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J Atheroscler Thromb, 2012; 19: 263-275","DOI":"10.5551\/jat.10603"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol, 1997; 29: 121-127","DOI":"10.1006\/jmcc.1996.0257"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Furuhashi M, Omori A, Matsumoto M, Kataoka Y, Tanaka M, Moniwa N, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T: Independent Link Between Levels of Proprotein Convertase Subtilisin\/Kexin Type 9 and FABP4 in a General Population Without Medication. Am J Cardiol, 2016; 118: 198-203","DOI":"10.1016\/j.amjcard.2016.04.037"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T, Ikewaki K, Inagaki K, Shoji T, Bujo H, Miida T, Yoshida M, Kuzuya M, Yamashita S: Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. J Atheroscler Thromb, 2020; 27: 409-417","DOI":"10.5551\/jat.50187"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K, Working Group by Japan Atherosclerosis Society for Making Guidance of Familial H: Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 751-770","DOI":"10.5551\/jat.CR003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, Sohmiya K, Shimamoto K, Itakura K: Defect in human myocardial long-chain fatty acid uptake is caused by FAT\/CD36 mutations. J Lipid Res, 2001; 42: 751-759","DOI":"10.1016\/S0022-2275(20)31637-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, Yamashita S, Yokote K, Joint Working Group by Japan Pediatric S, Japan Atherosclerosis Society for Making Guidance of Pediatric Familial H: Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 539-553","DOI":"10.5551\/jat.CR002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tada H, Nohara A, Inazu A, Sakuma N, Mabuchi H, Kawashiri MA: Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease. J Atheroscler Thromb, 2018; 25: 783-789","DOI":"10.5551\/jat.RV17024"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tada H, Okada H, Nomura A, Yashiro S, Nohara A, Ishigaki Y, Takamura M, Kawashiri MA: Rare and Deleterious Mutations in ABCG5\/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype. Circ J, 2019; 83: 1917-1924","DOI":"10.1253\/circj.CJ-19-0317"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nomura A, Emdin CA, Won HH, Peloso GM, Natarajan P, Ardissino D, Danesh J, Schunkert H, Correa A, Bown MJ, Samani NJ, Erdmann J, McPherson R, Watkins H, Saleheen D, Elosua R, Kawashiri MA, Tada H, Gupta N, Shah SH, Rader DJ, Gabriel S, Khera AV, Kathiresan S: Heterozygous ABCG5 Gene Deficiency and Risk of Coronary Artery Disease. Circ Genom Precis Med, 2020; 13: 417-423","DOI":"10.1161\/CIRCGEN.119.002871"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC: Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation, 2016; 133: 1067-1072","DOI":"10.1161\/CIRCULATIONAHA.115.018791"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nanchen D, Gencer B, Auer R, Raber L, Stefanini GG, Klingenberg R, Schmied CM, Cornuz J, Muller O, Vogt P, Juni P, Matter CM, Windecker S, Luscher TF, Mach F, Rodondi N: Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. Eur Heart J, 2015; 36: 2438-2445","DOI":"10.1093\/eurheartj\/ehv289"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Miyake Y, Kimura R, Kokubo Y, Okayama A, Tomoike H, Yamamura T, Miyata T: Genetic variants in PCSK9 in the Japanese population: rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population. Atherosclerosis, 2008; 196: 29-36","DOI":"10.1016\/j.atherosclerosis.2006.12.035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hori M, Ohta N, Takahashi A, Masuda H, Isoda R, Yamamoto S, Son C, Ogura M, Hosoda K, Miyamoto Y, Harada-Shiba M: Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients. Atherosclerosis, 2019; 289: 101-108","DOI":"10.1016\/j.atherosclerosis.2019.08.004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Khera AV, Won HH, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S, Kathiresan S: Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol, 2016; 67: 2578-2589","DOI":"10.1016\/j.jacc.2016.03.520"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, Mitani T, Sekiguchi S, Lipsky R, Kralisz U, Jamieson GA: A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36). Blood, 1990; 76: 1698-1703","DOI":"10.1182\/blood.V76.9.1698.1698"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yanai H, Chiba H, Fujiwara H, Morimoto M, Abe K, Yoshida S, Takahashi Y, Fuda H, Hui SP, Akita H, Kobayashi K, Matsuno K: Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost, 2000; 84: 436-441","DOI":"10.1055\/s-0037-1614041"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y: CD36 deficiency associated with insulin resistance. Lancet, 2001; 357: 686-687","DOI":"10.1016\/S0140-6736(00)04138-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Furuhashi M, Ura N, Nakata T, Tanaka T, Shimamoto K: Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med, 2004; 21: 952-953","DOI":"10.1111\/j.1464-5491.2004.01248.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ: CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res, 2003; 44: 2270-2277","DOI":"10.1194\/jlr.M300143-JLR200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Rashid S, Tavori H, Brown PE, Linton MF, He J, Giunzioni I, Fazio S: Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms. Circulation, 2014; 130: 431-441","DOI":"10.1161\/CIRCULATIONAHA.113.006720"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/4\/29_58909\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:41:07Z","timestamp":1648878067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/4\/29_58909\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.58909","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"58909"}}